Page last updated: 2024-11-01

norfloxacin and Lymphoma, Non-Hodgkin

norfloxacin has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogata, K1
Tanabe, Y1
Iwakiri, K1
Ito, T1
Yamada, T1
Dan, K1
Nomura, T1

Other Studies

1 other study available for norfloxacin and Lymphoma, Non-Hodgkin

ArticleYear
Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy.
    Cancer, 1990, Jun-15, Volume: 65, Issue:12

    Topics: Adult; Amphotericin B; Drug Combinations; Flucytosine; Humans; Leukemia, Myeloid, Acute; Lymphoma, N

1990